baber/WOPTO huggingface dataset:
Patent NZ-307584-A (NZ)
Title: Annular separators for double walled pipe structures
Inventor: PICKING KENNETH DAVID
IPC: F16L7/02
Filed: 1996-05-13
Abstract: PCT No. PCT/GB96/01129 Sec. 371 Date Oct. 30, 1997 Sec. 102(e) Date Oct. 30, 1997 PCT Filed May 13, 1996 PCT Pub. No. WO96/36831 PCT Pub. Date Nov. 21, 1996An annular bulkhead for separating the inner and outer generally coaxial pipes of a double walled pipe structure wherein the bulkhead is in the form of an annular resilient member dimensioned to fit, in use, the annular space between the pipes, wherein the annular resilient member is supported on each axial side thereof by means of at least partial annular rigid rings divided into separate segments and secured together through the resilient annular member.
Patent NZ-316124-A (NZ)
Title: Pattern recognition for speech recognising noise signals signatures
Inventor: DOWNEY SIMON NICHOLAS
IPC: G10L25/87
Filed: 1996-08-23
Abstract: A pattern recognition apparatus includes a store of allowable and non-allowable reference patterns, and a comparator for comparing successive portions of an input signal with each of the reference patterns and identifying a sequence of reference patterns that corresponds to the input signal.  An output outputs a signal indicating the sequence of reference patterns deemed to correspond to the input signal.  One or more portions of the input signal which are deemed not to correspond to an allowable reference pattern are also identified and from this identified portion an additional non allowable reference pattern is generated for subsequent use by the comparator.  The apparatus is useful for the recognition of telephone speech in the presence of noise.
Patent NZ-333252-A (NZ)
Title: Device for the metered transfer of several but similar liquids
Inventor: KOPL MANFRED
IPC: B67D7/04
Filed: 1997-05-24
Abstract: The invention concerns a device for the measured transferring of several liquids of the same kind, in particular a petrol pump for liquid fuels wherein the liquid extracted from a tank (8, 9, 10) using one of the pumps (5, 6, 7) allocated to the respective liquid is transferred from one of the fuel dispensers (2, 3, 4) allocated to the respective liquid whilst being measured at the same time. What is new is a common liquid measuring device (1) for the liquids with valves (13 to 18) arranged upstream and downstream forming a delivery connection from one of the pumps (5 to 7) via the measuring device (1) to the allocated fuel dispenser (2, 3, 4).
Patent NZ-502744-A (NZ)
Title: A roulette wheel assembly and table arrangement
Inventor: MURPHY PAUL A
IPC: A63F5/04
Filed: 1998-08-28
Abstract: A roulette wheel assembly and table arrangement includes a roulette wheel (1) rotatably mounted in a wheel bowl (5), and driven by an electric motor (6). Thirty-seven slot compartments (11) are located around the wheel circumference to receive a roulette ball (15).  In operation the wheel (1) is rotated and the slot compartment floor (14) is lowered to allow a ball (15) from the previous game to be thrown outwardly and fall into a ball magazine (22).   A firing breech (24) is opened to allow a ball (15) to enter a firing chamber (26).  On the command, an air blower (27) blows the ball (15) into a firing tube (28), which propels the ball (15) tangentially onto the bowl (5) in the opposite direction to the travel of the wheel (1). The ball (15) travels across the bowl (5) onto the wheel (1) and finally lands in a compartment (11).   Each player around the table (37) has a betting station (38) giving the betting choices that make up the game.
Patent NZ-503235-A (NZ)
Title: Amino-terminally truncated RANTES as chemokine antagonists
Inventor: PROOST PAUL
IPC: C12N1/21
Filed: 1998-09-28
Abstract: Amino-terminally truncated RANTES, lacking NH2-terminal amino acids corresponding to amino acid residues 1 or 1-2 of the naturally-occurring RANTES and having chemokine antagonistic activity.  Also described are DNA sequences encoding these proteins, and the recombinant process for preparing them.  Further disclosed are uses of the proteins in therapy and/or diagnosis of diseases in which an antagonistic activity of the chemokine effects is required and pharmaceutical compositions comprising them.
Patent NZ-503376-A (NZ)
Title: Genetically modified Salmonella sp having a modified msbB gene useful for treating tumours
Inventor: BERMUDES DAVID
IPC: A61K35/74
Filed: 1998-09-09
Abstract: A mutant Salmonella sp. having a genetically modified msbB gene in which the mutant Salmonella is capable of targeting solid tumours. The Salmonella sp. contains a genetically modified msbB gene as well as a genetic modification in a biosynthetic pathway gene such as the purI gene. Also described are the therapeutic use of the mutant Salmonella for growth inhibition and/or reduction in volume of solid tumours.
Patent NZ-510846-A (NZ)
Title: Oral combination of lufenuron and nitenpyram against fleas
Inventor: TINEMBART OLIVIER
IPC: A01N43/40
Filed: 1999-10-07
Abstract: Veterinary compositions comprising synergistic amounts of a nitroenamine derivative of formula (I) and a benzoylurea derivative of formula (II), wherein R1 and R2 is hydrogen, alkyl or cycloalkyl; R3 is hydrogen or alkyl; and A is heterocyclyl which is unsubstituted or substituted once or repeatedly by identical or different halogen atoms; and where X is halogen, X1 and X2 is hydrogen or halogen; Y is partially or completely halogenated alkoxy, or partially or completely halogenated alkoxy which is interrupted by one oxygen atom, or partially or completely halogenated alkenyl; Y1, Y2 and Y3 is hydrogen or halogen; Z1 and Z2 is hydrogen or alkyl; and a physiologically acceptable formulation excipient; and their use in controlling fleas on domestic animals.
Patent NZ-512939-A (NZ)
Title: Graphical user interface having only one window with all elements being active (changable properties)
Inventor: WARREN PETER
IPC: G06F9/44
Filed: 2000-11-13
Abstract: A graphical user interface is disclosed that includes a single window in which active elements are painted. Each active element is not independent of the single window and includes a configuration panel and at least one tool operable with each active element to allow a user to alter the characteristics of the active element. Also included is a semi-automatic view generator operable on each active element provided the active element is a single record view of an object or a multi-record view of a group of like objects.
Patent NZ-515156-A (NZ)
Title: Pedal device
Inventor: BADARNEH ZIAD
IPC: B62M3/08
Filed: 1999-05-06
Abstract: Pedal device for rotary attachment to a pedal crank arm of physical training apparatus, e.g. a bicycle, said device comprising a first pedal rotatably attached to a pedal shaft (3), said pedal shaft at a free end thereof firmly attachable to said crank arm, and said first pedal having a first pedal engagement face for use in carrying out conventional training exercise. Said device is provided with a second pedal (1) tiltably attached to said first pedal about an axis extending transversely through a longitudinal axis of said pedal shaft and parallel to said first pedal face approximately midway between an inner and an outer end thereof. Said second pedal has second pedal engagement face (6) facing away from said first pedal engagement face and spaced from said transversely extending axis, and said second pedal is tiltable to either side relative to said first pedal by an acute angle, e.g. in the range 0-35 degrees.
Patent NZ-518317-A (NZ)
Title: Eyeglass device
Inventor: IFERGAN THIERRY
IPC: G02C9/00
Filed: 2000-09-25
Abstract: An eyeglass device comprised of a primary eyeglass frame (20) and an auxiliary eyeglass frame (10), each containing lenses therein. The primary eyeglass frame (20) includes a bridge and earpieces, which are connected to extensions (21) on each side of the frame. The bridge may be made of a flexible memory alloy such as NiTi or CuAlBe. The extensions (21) have magnets mounted on the undersides of them. The auxiliary eyeglass frame (10) also includes a bridge and temporal extensions (11). These extensions of the auxiliary eyeglass frame have magnets mounted to the tops of them. The magnets engage magnetically with each other to connect the auxiliary eyeglass frame to the primary eyeglass frame. The flexible bridges of the primary and auxiliary eyeglass frames assist in preventing the auxiliary eyeglass frame in case it jostled by the wearer because they can withstand slight distortion.
Patent NZ-520351-A (NZ)
Title: System and method of panelized construction
Inventor: WEISS ARVIN
IPC: E04D13/03
Filed: 2000-11-29
Abstract: A system and method of panelized construction for use in construction of a building module, such as a residential housing addition. A plurality of pre-fabricated panels, such as wall panels, roof panels, floor panels, and ceiling panels may be provided to decrease on-site building time. The panels may comprise one or more covering layers pre-installed on a frame. The panels may also comprise pre-installed insulation or other core materials. The panels may further comprise a pre-installed portion of a house system, such as an electrical system. Additionally, the panels may comprise pre-installed windows, doors, or skylights. The panels may be designed to meet the residential building code requirements of one or more jurisdictions to decrease permitting time and inspection delays. The panels and other materials may be included in a building kit for a building module to be constructed by contractors or do-it-yourselfers.
Patent NZ-522145-A (NZ)
Title: Supplementary endo-capsular lens and method of implantation
Inventor: HO ARTHUR
IPC: A61F2/16
Filed: 2001-05-08
Abstract: A supplemental endo capsular lens (SECL) for inserting and embedding within either a gel or polymer inside the capsule of the crystalline lens during phaco-ersatz or similar surgical procedures in order to supplement the refractive power of the eye with a view to (1) correcting ametropia while (2) maintaining a useable amplitude of accommodation. A method of inserting and embedding the SECL within either a gel or polymer inside the capsule of the crystalline lens is also described.
Patent NZ-522762-A (NZ)
Title: Propulsion system for a boat having an intake for communicating with fluid source such as sea water
Inventor: BURNS ALAN ROBERT
IPC: F02K1/36
Filed: 2001-06-07
Abstract: A propulsion system comprises of a flow passage (173) having an intake (175) for communicating with a source of working fluid such as seawater and an outlet (177). A mixing zone (209) is disposed within the flow passage (173) between the intake (175) and the outlet (177). An injection means including annular nozzle (217) is provided for injecting a hot compressible driving fluid (175) such as steam into the mixing zone (209) in a flow direction towards the outlet (177). The arrangement is such that the interaction between the steam and the seawater in the mixing zone (207) develops a pressure reduction in the mixing zone (207) to cause seawater to be drawn from the source into the mixing zone (207) and propelled towards the outlet (177). A marine drive unit incorporating the propulsion system is also claimed. A heat recovery system comprising a refrigerant circuit with a heat exchanger for extracting heat from a heat source to vaporise a refrigerant in the circuit and means to convert heat energy in the vaporised refrigerant to torque and, a nozzle means (217) having an inlet, an outlet (177) and a flow passage (173) the size of which is selectively variable are also disclosed.
Patent NZ-523524-A (NZ)
Title: Cell fusion chamber
Inventor: JAROSZESKI MARK J
IPC: C12N13/00
Filed: 2001-02-16
Abstract: An apparatus for producing cell-cell fusion comprises a chamber (20) including two electrodes (30, 32) a porous substrate (34), a substrate support (36) and a port connection (38) to a vacuum source. The electrofusion is conducted in the chamber by first placing a suspension of cells between the two electrodes, then applying a vacuum sufficient to draw liquid from the suspension toward one side (40) of the substrate and through the pores of the substrate, but not so complete as to evacuate the entire liquid medium, so that the cells in the suspension remain substantially viable. Layers of cells are maintained on the one side of the substrate, resulting in cells in contact with each other in the space between the two electrodes. After deposition, one or more DC pulses are administrated to the electrodes to induce fusion of cells that are in cell-to-cell contact between the electrodes.
Patent NZ-529715-A (NZ)
Title: Assay system
Inventor: HOLTLUND JOSTEIN
IPC: G01N35/00
Filed: 2002-05-09
Abstract: An assay apparatus comprising: i) an assay cartridge (52, 53) comprising at least one well (57-62) and a pipette (50) positionable in at least one said well; ii) a holder arranged to receive said cartridge; iii) drive means operable to position said pipette in selected wells of said cartridge; iv) a gas pressure applicator couple able to said pipette whereby to cause liquid flow through said membrane; and v) a radiation detector operable to detect radiation from a well of said cartridge or from said pipette.
Patent NZ-530705-A (NZ)
Title: Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
Inventor: IBRAHIM PRABHA
IPC: A61K31/496
Filed: 2002-07-18
Abstract: Disclosed are heterocyclic derivatives of the formula I, wherein R1, R2, R3, R4, R5, R6, R7 and R8 are hydrogen or C1-6 alkyl; T is oxygen, sulfur, or NR11, in which R11 is hydrogen or C1-6 alkyl; V is -N<; X1 is optionally substituted aryl; X2 is optionally substituted heteroaryl; Y is optionally substituted monocyclic heteroarylenyl; and Z1 and Z2 are independently alkylene of 1-4 carbon atoms. The compounds are described to be used for the preparation of a pharmaceutical composition for treating a disease state in a mammal that is alleviable by treatment with a fatty acid oxidation inhibitor. These diseases are explained to include ventricular arrhythmia, congestive heart disease, diabetes, and skeletal muscles damage.
Patent NZ-535828-A (NZ)
Title: Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such
Inventor: ARIMILLI MURTY N
IPC: C07D231/20
Filed: 2003-04-25
Abstract: Disclosed are compounds of formula I wherein the substituents are as described in the specification. Compounds of the sort disclosed have HIV protease activity and are useful in the treatment of HIV infection.
Patent NZ-537142-A (NZ)
Title: Novel formate salt of O-desmethyl-venlafaxine
Inventor: HADFIELD ANTHONY FRANCIS
IPC: C07C215/48
Filed: 2003-06-09
Abstract: Disclosed is O-desmethylvenlafaxine formate, and a method for its preparation comprising reacting O-desmethlyvenlafaxine with formic acid.
Patent NZ-538058-A (NZ)
Title: Quinuclidine derivatives and their use for treating disorders related to CNS and PNS
Inventor: PETERS DAN
IPC: A61K31/439
Filed: 2003-08-13
Abstract: Quinuclidine derivatives of formula (I) and their use as pharmaceuticals are disclosed, wherein the substituents for the variables are as defined in the specification. Due to their pharmacological profile these compounds may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.
Patent NZ-538753-A (NZ)
Title: Transformed plants with enhanced prenylquinone biosynthesis
Inventor: MATRINGE MICHEL
IPC: C12P17/02
Filed: 2003-09-10
Abstract: A transformed plant comprising: (1) a first gene that is functional in plants comprising a nucleotide sequence encoding a prephenate dehydrogenase, and (2) a second gene that is functional in plants comprising a nucleotide sequence encoding a p-hydroxylphenylpyruvate dioxygenase, wherein the plant overexpresses the prephenate dehydrogenase and the p-hydroxyphenylpyruvate dioxygenase. Also disclosed is a method for producing said plants and a method for cultivating said plants.
Patent NZ-539589-A (NZ)
Title: Purine compounds and uses thereof as cannabinoid receptor ligands
Inventor: GRIFFITH DAVID ANDREW
IPC: C07D473/30
Filed: 2003-10-21
Abstract: Disclosed is a compound of formula (I) wherein: A and B are optionally substituted aryl or optionally substituted heteroaryl; R1 is hydrogen, (C1-C4) alkyl, halo-substituted (C1-C4)alkyl, or (C1- C4) alkoxy; and R4 is as defined in the specification. The compounds are useful as cannabinoid receptor ligands, in particular CB-1 receptor ligands.
Patent NZ-545555-A (NZ)
Title: Methods and apparatus for determining device integrity
Inventor: MCLEAN IVAN HUGH
IPC: H04B17/40
Filed: 2004-08-17
Abstract: Apparatus for providing a dynamic integrity check of a device comprises selection logic that operates to select a selected integrity application from one or more integrity applications. The selected integrity application operates to generate a unique preselected integrity response. Logic that operates to download the selected integrity application is transmitted for execution on the device. Logic that operates to receive a response from the selected integrity application is received. Logic that operates to determine whether or not the response is the preselected integrity response is determined.
Patent NZ-546735-A (NZ)
Title: Information distribution system
Inventor: CHU LESTER K
IPC: G06Q30/00
Filed: 2004-09-24
Abstract: An information distribution system is disclosed. Buyers identify potential sources for goods and services that are desirable to the buyer. Buyers can focus their access to listings (104)of seller information by identifying desirable attributes, including geography attributes (108) relating to the location(s) of the seller; and category attributes (110) relating to the various categories of offerings that interest to the buyer. The use of geographical and categorical attributes (108) and (110) is not limited to their inclusion as part of the search terms. Instead, seller listings (104) can be organized into hierarchies of geography-based and category-based attributes (108 ) and (110) in a highly normalized fashion to enhance the ability of a buyer focus on the most desirable listings. The system can be configured to limit, order, or otherwise prioritize the information viewed by the buyer on the basis of the desired attributes identified by the buyer.
Patent NZ-547111-A (NZ)
Title: A sill for a bi-fold door assembly
Inventor: LLOYD ROSS
Filed: 2005-01-28
Abstract: A sill for a bi-fold door assembly comprises at least two parts, a first part defining a part of an outside side of an elongated sill track cavity 19 and a second part defining part of an inside side of the cavity 19. A sill trolley 11can be inserted or removed from the sill track cavity 19 by disassembly of the first part relative to the second part, and is held captive in the cavity 19 when the parts are assembled.
Patent NZ-548865-A (NZ)
Title: A humanised binding molecule for the preparation of a medicament for the treatment of autoimmune diseases, transplant rejection, psoriasis, IBD and allergies.
Inventor: AVERSA GREGORIO
IPC: A61P25/00
Filed: 2002-02-11
Abstract: Disclosed is a molecule comprising at least one antigen binding site, comprising in sequence the hypervariable regions CDR1, CDR2 and CDR3, said CDR1 having the amino acid sequence Asn-Tyr-lle-lle-His (NYIH), said CDR2 having the amino acid sequence Tyr-Phe-Asn-Pro-Tyr-Asn-His-Gly-Thr-Lys-Tyr-Asn-Glu-Lys-Phe-Lys-Gly (YFNPYNHGTKYNEKFKG) and said CDR3 having the amino acid seuqnce Ser-Gly-Pro-Tyr-Ala-Trp-Phe-Asp-Thr (SGPYAWFDT); e.g. further comprising in sequence the hypervariable regions CDR1', CDR2' and CDR3', CDR1' having the amino acid sequence Arg-Ala-Ser-Gln-Asn-lle-Gly-Thr-Ser-lle-Gln 8RASQNIGTSIQ), CDR', having the amino acid sequence Ser-Ser-Ser-Glu-Ser-lle-Ser (SSSESIS) and CDR3' having the amino acid sequence Gln-Gln-Ser-Asn-Thr-Trp-Pro-Phe-Thr (QQSNTWPFT), e.g. a chmieric or humanised antibody, useful as a pharmaceutical.
Patent NZ-553569-A (NZ)
Title: Luminescent signage component
Inventor: TO IVAN
Filed: 2004-09-08
Abstract: A luminescent signage component 10, comprising: a one-piece body 20 in the form of a sign plate made from a single layer of material, having a first face 22 and a second face 24; at least one inlaid cavity 26 in the body 20 defining a message conveying indicia selected from one of a series of alphanumeric characters or a graphic symbol, the at least one cavity being closed by an integrally formed transparent window positioned across the second face 24; luminescent epoxy 28 filling the at least one cavity 26 between the first face 22 and the second face 24; and a constant light source 14 backlighting the at least one inlaid cavity 26 such that the constant light source 14 causes the luminescent epoxy 28 to emit a luminescent glow 32 when illuminated, and to emit a luminescent glow 32 when the constant light source 14 is interrupted.
Patent NZ-555039-A (NZ)
Title: Polypeptides having antimicrobial activity and polynucleotides encoding same
Inventor: MYGIND PER HOLSE
IPC: A01H5/00
Filed: 2005-11-11
Abstract: Disclosed are polypeptides having antimicrobial activity and polynucleotides having a nucleotide sequence which encodes for the polypeptides. Further disclosed are nucleic acid constructs, vectors, and host cells comprising the nucleic acid constructs as well as methods for producing and using the polypeptides.
Patent NZ-555437-A (NZ)
Title: Methods for the production of ansamitocins
Inventor: KUO CYNTHIA
IPC: C07D491/02
Filed: 2005-12-12
Abstract: Provided is a process for preparing purified ansamitocins of a specified structure, comprising the steps of: 1) culturing an ansamitocin-producing microorganism in a liquid culture medium; 2) solid phase extraction of ansamitocins from the culture medium onto a hydrophobic resin; 3) isocratic or gradient elution of ansamitocins from the resin using an organic solvent or an organic solvent combined with water; 4) concentrating the extracted ansamitocins; and 5) optionally purifying the ansamitocins by anyone of a) b), c) and d): a) adsorption chromatography over silica gel or alumina, b) crystallization, c) adsorption chromatography over silica gel or alumina followed by crystallization, and d) crystallization followed by adsorption chromatography over silica gel or alumina. Further provided are variants of the method and specific temperatures and solvents for the purification process.
Patent NZ-570394-A (NZ)
Title: A process for functionalizing titanium metal surfaces with nanometric particles of titanium and products thus functionalized
Inventor: BALDI GIOVANNI
IPC: A61L27/30
Filed: 2007-02-02
Abstract: Disclosed is a process for functionalizing titanium metal surfaces with nanometric particles of titanium. The process includes the steps of: immersing the article to be functionalized in a suspension of nanometric particles of titanium dioxide; when the article is completely wetted, heating the article to remove the solvent; and subjecting the article to a thermal cycle.